Clincosm LogoSign in Get a demo

gastroesophageal junction cancer

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Seoul (afatinib, paclitaxel)

Completed
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System, Yonsei Canc
Jan 26, 2023

Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)

Recruiting
  • Advanced Solid Tumors
  • +5 more
  • Scottsdale, Arizona
  • +7 more
Jan 23, 2023

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, Korea, Republic of, Taiwan (Bemarituzumab, CAPOX, SOX)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Northport, New York
  • +13 more
Jan 4, 2023

Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • margetuximab
  • +4 more
  • Scottsdale, Arizona
  • +72 more
Aug 24, 2022

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (Pembrolizumab, Placebo, Cisplatin)

Active, not recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Pembrolizumab
  • +7 more
  • Duarte, California
  • +170 more
Aug 18, 2022

Gastric Cancer, Gastroesophageal Junction Cancer Trial in China (Pembrolizumab, Placebo, Cisplatin)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Pembrolizumab
  • +7 more
  • Beijing, Beijing, China
  • +12 more
Aug 17, 2022

Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)

Recruiting
  • Esophagogastric Tumors
  • +9 more
  • Basking Ridge, New Jersey
  • +6 more
Jul 8, 2022

Gastric Cancer, Esophageal Cancer, Stomach Cancer Trial in Saint Louis (CA-4948, 5-FU, Leucovorin)

Not yet recruiting
  • Gastric Cancer
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 27, 2022

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Nanjing (MAX-40279)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Nanjing, Jingsu, China
    Nanjing Drum Tower Hospital of Nanjing University Medical School
May 29, 2022

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (BBI608, Paclitaxel, Placebo)

Completed
Has Results
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Scottsdale, Arizona
  • +262 more
Apr 4, 2022

Breast Cancer, Gastric Cancer, Gastroesophageal Junction Cancer Trial in China, Korea, Republic of, Taiwan (ZW25, Docetaxel,

Active, not recruiting
  • Breast Cancer
  • +2 more
  • ZW25
  • +4 more
  • Beijing, Beijing, China
  • +21 more
Apr 1, 2022

Localized Stage I-III Esophageal Cancer, Gastroesophageal Junction Cancer Trial in United States (nutritional and functional

Completed
  • Localized Stage I-III Esophageal Cancer
  • Gastroesophageal Junction Cancer
  • nutritional and functional assessments
  • Basking Ridge, New Jersey
  • +6 more
Mar 7, 2022

STRENGTH Expansion

Withdrawn
  • Esophageal Cancer
  • Gastroesophageal Junction Cancer
  • STRENGTH
  • Aurora, Colorado
    University of Colorado Hospital
Nov 16, 2021

Cervical Cancer, Gastric Cancer, Stomach Cancer Trial in United States (INCAGN02390)

Completed
  • Cervical Cancer
  • +20 more
  • Los Angeles, California
  • +3 more
Nov 12, 2021

Esophageal Cancer, Gastroesophageal Junction Cancer, Anastomotic Leak Trial in Guangzhou (Porcine Fibrin Sealant (PFS), Surgery)

Completed
  • Esophageal Cancer
  • +2 more
  • Porcine Fibrin Sealant (PFS)
  • Surgery
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 22, 2021

Dose Escalation, Safety, Preliminary Efficacy Trial in Worldwide (LDE225, BKM120)

Completed
  • Dose Escalation
  • +11 more
  • Los Angeles, California
  • +22 more
Dec 16, 2020

Stomach Cancer, Gastroesophageal Junction Cancer Trial in Frankfurt (FLOT alone, FLOT + Herceptin/Pertuzumab)

Completed
  • Stomach Cancer
  • Gastroesophageal Junction Cancer
  • FLOT alone
  • FLOT + Herceptin/Pertuzumab
  • Frankfurt, Germany
    Institute for Clinical Cancer Research Krankenhaus Nordwest
Aug 10, 2020

Gastric Cancer, Gastroesophageal Junction Cancer Trial in United States (Ramucirumab, Trastuzumab, Capecitabine)

Terminated
Has Results
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Basking Ridge, New Jersey
  • +5 more
Jan 6, 2020

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Turkey (Oxaliplatin, Radiation, Capecitabine)

Completed
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Adana, Turkey
  • +8 more
Oct 7, 2019

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Greece (Cisplatin-5FU-Afatinib)

Completed
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Athens, Greece
  • +14 more
Sep 2, 2019

PD-1, Chemoradiotherapy, Gastroesophageal Junction Cancer Trial (PD-1)

Not yet recruiting
  • PD-1
  • +2 more
  • (no location specified)
Aug 17, 2019

Esophageal Cancer, Gastroesophageal Junction Cancer Trial in New York (Sorafenib, administered orally, CT/MRI)

Completed
Has Results
  • Esophageal Cancer
  • Gastroesophageal Junction Cancer
  • Sorafenib, administered orally
  • CT/MRI
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 13, 2019

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, Korea, Republic of, Taiwan (Irinotecan, Nimotuzumab)

Terminated
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Kashiwa, Chiba, Japan
  • +36 more
Mar 23, 2018

Human Epidermal Growth Factor Receptor 2 Advanced Gastric

Completed
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
    • Busan, Korea, Republic of
    • +13 more
    Jul 6, 2017

    HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer Trial in United States (MM-111, Paclitaxel,

    Terminated
    Has Results
    • HER-2 Gene Amplification
    • +3 more
    • Birmingham, Alabama
    • +20 more
    Jun 19, 2017